Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Gralla

Showing results (191-200 of 326) with videos related to

Pageof 33
Sort By:
American Journal of Clinical Oncology|December 1, 1985
Phase 1 trial of levonantradol in chemotherapy-induced emesisL B Tyson, R J Gralla, R A Clark, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 19, 2004
Delayed emesis: moderately emetogenic chemotherapyFausto Roila, David Warr, Rebecca A Clark-Snow, et al.
Toxicology and Applied Pharmacology|May 1, 1977
Toxic effects of hexachlorobenzene after daily administration to beagle dogs for one yearE J Gralla, R W Fleischman, Y K Luthra, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 11, 2014
Efficacy and safety of NEPA, an oral combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy: a randomized dose-ranging pivotal studyP J Hesketh, G Rossi, G Rizzi, et al.
The New England Journal of Medicine|August 18, 1983
Extrapyramidal reactions with high-dose metoclopramideM G Kris, L B Tyson, R J Gralla, et al.
Cancer Treatment Reports|June 1, 1985
Adenocarcinoma of unknown primary origin: treatment with vindesine and doxorubicinJ J Fiore, D P Kelsen, R J Gralla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1988
Phase II study of 10-ethyl-10-deaza-aminopterin in patients with stage III and IV non-small-cell lung cancerK Y Shum, M G Kris, R J Gralla, et al.
American Journal of Clinical Oncology|February 1, 1993
Phase II trial of a single intravenous dose of ondansetron in patients receiving cisplatin > or = 100 mg/m2M G Kris, R A Clark, L B Tyson, et al.
Cancer Investigation|March 26, 1998
Efficacy of intravenous granisetron to control nausea and vomiting during multiple cycles of cisplatin-based chemotherapyH L Ritter, R J Gralla, S W Hall, et al.
Cancer Clinical Trials|January 1, 1981
Phase II evaluation of metoprine in patients with non-small-cell lung carcinomaG R Lynch, R J Gralla, D P Kelsen, et al.
Pageof 33

Showing results (191-200 of 326) with videos related to

Sort By:
Pageof 33
American Journal of Clinical Oncology|December 1, 1985
Phase 1 trial of levonantradol in chemotherapy-induced emesisL B Tyson, R J Gralla, R A Clark, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 19, 2004
Delayed emesis: moderately emetogenic chemotherapyFausto Roila, David Warr, Rebecca A Clark-Snow, et al.
Toxicology and Applied Pharmacology|May 1, 1977
Toxic effects of hexachlorobenzene after daily administration to beagle dogs for one yearE J Gralla, R W Fleischman, Y K Luthra, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 11, 2014
Efficacy and safety of NEPA, an oral combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy: a randomized dose-ranging pivotal studyP J Hesketh, G Rossi, G Rizzi, et al.
The New England Journal of Medicine|August 18, 1983
Extrapyramidal reactions with high-dose metoclopramideM G Kris, L B Tyson, R J Gralla, et al.
Cancer Treatment Reports|June 1, 1985
Adenocarcinoma of unknown primary origin: treatment with vindesine and doxorubicinJ J Fiore, D P Kelsen, R J Gralla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1988
Phase II study of 10-ethyl-10-deaza-aminopterin in patients with stage III and IV non-small-cell lung cancerK Y Shum, M G Kris, R J Gralla, et al.
American Journal of Clinical Oncology|February 1, 1993
Phase II trial of a single intravenous dose of ondansetron in patients receiving cisplatin > or = 100 mg/m2M G Kris, R A Clark, L B Tyson, et al.
Cancer Investigation|March 26, 1998
Efficacy of intravenous granisetron to control nausea and vomiting during multiple cycles of cisplatin-based chemotherapyH L Ritter, R J Gralla, S W Hall, et al.
Cancer Clinical Trials|January 1, 1981
Phase II evaluation of metoprine in patients with non-small-cell lung carcinomaG R Lynch, R J Gralla, D P Kelsen, et al.
Pageof 33